Starred
WHAT THE NEIGHBORS SAY
Platelet secretory behaviour: as diverse as the granules … or not?
Revisiting the tale of venous thromboembolism in hospitalized medical patients
Central venous catheters and upper extremity deep vein thrombosis in medical inpatients: the Medical Inpatients and Thrombosis (MITH) Study
Bemiparin for thromboprophylaxis after benign gynecologic surgery: a randomized clinical trial
Clotting factor product administration and same-day occurrence of thrombotic events, as recorded in a large healthcare database during 2008–2013
Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial
Ex vivo addition of fibrinogen concentrate improves the fibrin network structure in plasma samples taken during liver transplantation
Rediscovering the wound hematoma as a site of hemostasis during major arterial hemorrhage
Comparison of platelet-derived and plasma factor VIII efficacy using a novel native whole blood thrombin generation assay
Four-factor prothrombin complex concentrate reverses apixaban-associated bleeding in a rabbit model of acute hemorrhage
Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction
Acute hemorrhagic complications are associated with lower coated-platelet levels in non-lacunar brain infarction
A TMEM16F point mutation causes an absence of canine platelet TMEM16F and ineffective activation and death-induced phospholipid scrambling
Modified platelet deposition on matrix metalloproteinase 13 digested collagen I
Growth arrest-specific 6 regulates thrombin-induced expression of vascular cell adhesion molecule-1 through forkhead box O1 in endothelial cells
Deficiency of P-selectin glycoprotein ligand-1 is protective against the prothrombotic effects of interleukin-1β
Evaluation of and recommendation for the nomenclature of the CPB2 gene product (also known as TAFI and proCPU): communication from the SSC of the ISTH
Validation of viscoelastic coagulation tests during cardiopulmonary bypass: comment
Validation of viscoelastic coagulation tests during cardiopulmonary bypass: reply
The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study: comment
The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study: reply
It's Time to Renew Your Membership with the ISTH, the Leading Global Community of Specialists in Thrombosis and Hemostasis